SUBSCRIPTION AGREEMENT
SUBSCRIPTION
AGREEMENT
made as
of this ___ day of ____________, 2008, between Transdel Pharmaceuticals, Inc.,
a
Delaware corporation (the “Company”),
and
the undersigned (the “Subscriber”).
WHEREAS,
the
Company is offering in a private placement to accredited investors Units at
a
purchase price of $110,000 per Unit for an aggregate purchase price of
$4,000,000 (the “Offering”).
Each
Unit consists of 50,000 shares of the Company’s common stock, par value $0.001
per share (the “Common
Stock”),
and a
five-year, redeemable warrant to purchase 6,250 shares of Common Stock at a
cash
exercise price of $4.40 per share and a cashless exercise price of $5.50 per
share (the “Warrants”).
As
used herein, the term “Units” means such Units, and all Common Stock and
Warrants underlying the Units), and
WHEREAS,
the
Subscriber desires to subscribe for the number of Units set forth on the
signature page hereof, on the terms and conditions hereinafter set
forth.
NOW,
THEREFORE,
for and
in consideration of the premises and the mutual covenants hereinafter set forth,
the parties hereto do hereby agree as follows:
I.
|
SUBSCRIPTION
FOR AND REPRESENTATIONS AND COVENANTS OF
SUBSCRIBER
|
1.1 Subject
to the terms and conditions hereinafter set forth, the Subscriber hereby
subscribes for and agrees to purchase from the Company such number of Units
set
forth upon the signature page hereof, at a price equal to $110,000 per Unit,
and
the Company agrees to sell such to the Subscriber for said purchase price,
subject to the Company’s right to sell to the Subscriber such lesser number of
(or no) Units as the Company may, in its sole discretion, deem necessary or
desirable. The purchase price is payable by wire transfer of immediately
available funds, pursuant to the wire instructions attached as Exhibit
A
to this
Subscription Agreement.
1.2 The
Subscriber recognizes that the purchase of Units involves a high degree of
risk
in that (i) an investment in the Company is highly speculative and only
investors who can afford the loss of their entire investment should consider
investing in the Company and the Units; (ii) the Units are not registered under
the Securities Act of 1933, as amended (the “Act”),
or
any state securities law; (iii) there is no trading market for the Units, none
is likely ever to develop, and the Subscriber may not be able to liquidate
his,
her or its investment; (iv) transferability of the Units is extremely limited;
and (v) an investor could suffer the loss of his, her or its entire
investment.
1.3 The
Subscriber is an “accredited investor,” as such term in defined in Rule 501 of
Regulation D promulgated under the Act, and the Subscriber is able to bear
the
economic risk of an investment in the Units.
1.4 The
Subscriber has prior investment experience (including investment in non-listed
and non-registered securities), and has read and evaluated, or has employed
the
services of an investment advisor, attorney or accountant to read and evaluate,
all of the documents furnished or made available by the Company to the
Subscriber and to all other prospective investors in the Units, as well as
the
merits and risks of such an investment by the Subscriber. The Subscriber’s
overall commitment to investments which are not readily marketable is not
disproportionate to the Subscriber’s net worth, and the Subscriber’s investment
in the Units will not cause such overall commitment to become excessive. The
Subscriber, if an individual, has adequate means of providing for his or her
current needs and personal and family contingencies and has no need for
liquidity in his or her investment in the Units. The Subscriber is financially
able to bear the economic risk of this investment, including the ability to
afford holding the Units for an indefinite period or a complete loss of this
investment.
1.5 The
Subscriber acknowledges receipt and careful review of all documents furnished
in
connection with this transaction by the Company (collectively, the “Offering
Documents”)
and
has been furnished or made available by the Company during the course of this
transaction with all public information regarding the Company which the
Subscriber has requested or desires to know; and the Subscriber has been
afforded the opportunity to ask questions of and receive answers from duly
authorized officers or other representatives of the Company concerning the
terms
and conditions of the Offering, and any additional information which the
Subscriber has requested.
1.6 The
Subscriber acknowledges that the purchase of the Units may involve tax
consequences to the Subscriber and that the contents of the Offering Documents
do not contain tax advice. The Subscriber acknowledges that the Subscriber
must
retain his, her or its own professional advisors to evaluate the tax and other
consequences to the Subscriber of an investment in the Units. The Subscriber
acknowledges that it is the responsibility of the Subscriber to determine the
appropriateness and the merits of a corporate entity to own the Subscriber’s
Units and the corporate structure of such entity.
1.7 The
Subscriber acknowledges that this Offering has not been reviewed by the
Securities and Exchange Commission (the “SEC”)
or any
state securities commission, and that no federal or state agency has made any
finding or determination regarding the fairness or merits of the Offering.
The
Subscriber represents that the Units are being purchased for his, her or its
own
account, for investment only, and not with a view toward distribution or resale
to others. The Subscriber agrees that he, she or it will not sell or otherwise
transfer the Units unless they are registered under the Act or unless an
exemption from such registration is available.
1.8 The
Subscriber understands that the provisions of Rule 144 under the Act are not
available for at least six (6) months to permit resales of the Units or the
Common Stock and Warrants comprising the Units and even though the Company
will
use its best efforts to comply with the conditions for compliance with Rule
144,
there can be no assurance that the conditions necessary to permit such sales
under Rule 144 will be satisfied. The Subscriber understands that, except as
set
forth in the immediately preceding sentence, the Company is under no obligation
to comply with the conditions of Rule 144 or take any other action necessary
in
order to make available any exemption from registration for the sale of the
Units or the Common Stock and Warrants comprising the Units.
2
1.9 The
Subscriber understands that the Units have not been registered under the Act
by
reason of a claimed exemption under the provisions of the Act which depends,
in
part, upon his, her or its investment intention. In this connection, the
Subscriber understands that it is the position of the SEC that the statutory
basis for such exemption would not be present if his, her or its representation
merely meant that his, her or its present intention was to hold such securities
for a short period, such as the capital gains period of tax statutes, for a
deferred sale, for a market rise or for any other fixed period. The Subscriber
realizes that, in the view of the SEC, a purchase now with an intent to resell
would represent a purchase with an intent inconsistent with his, her or its
representation to the Company and the SEC might regard such a sale or
disposition as a deferred sale, for which such exemption is not
available.
1.10 The
Subscriber agrees to indemnify and hold the Company, its directors, officers
and
controlling persons and their respective heirs, representatives, successors
and
assigns harmless against all liabilities, costs and expenses incurred by them
as
a result of any misrepresentation made by the Subscriber contained herein or
any
sale or distribution by the Subscriber in violation of the Act (including,
without limitation, the rules promulgated thereunder), any state securities
laws, or the Company’s Certificate of Incorporation or By-laws, as amended from
time to time.
1.11 The
Subscriber consents to the placement of a legend on any certificate or other
document evidencing the Common Stock or the Warrants stating that such
securities have not been registered under the Act and setting forth or referring
to the restrictions on transferability and sale thereof. Assuming the Company
is
in compliance with its obligations under Rule 144 (and the Subscriber is in
compliance with its obligations under Rule 144) after the 6 month period noted
in Section 1.8, the Company will coordinate to have a legal opinion issued
that
will facilitate the removal of the restrictive legend on the securities to
allow
for the transferability and sale of the securities.
1.12 The
Subscriber understands that the Company will review and rely on this
Subscription Agreement without making any independent investigation; and it
is
agreed that the Company reserves the unrestricted right to reject or limit
any
subscription and to withdraw the Offering at any time.
1.13 The
Subscriber hereby represents that the address of the Subscriber furnished at
the
end of this Subscription Agreement is the undersigned’s principal residence, if
the Subscriber is an individual, or its principal business address if it is
a
corporation or other entity.
1.14 The
Subscriber acknowledges that if the Subscriber is a Registered Representative
of
a National Association of Securities Dealers, Inc. (“NASD”)
member
firm, the Subscriber must give such firm the notice required by the NASD’s
Conduct Rules, receipt of which must be acknowledged by such firm on the
signature page hereof.
1.15 The
Subscriber hereby acknowledges that neither the Company nor any persons
associated with the Company who may provide assistance or advice in connection
with the Offering (other than the placement agent, if one is engaged by the
Company) are or are expected to be members or associated persons of members
of
the NASD or registered broker-dealers under any federal or state securities
laws.
3
1.16 The
Subscriber hereby represents that, except as expressly set forth in the Offering
Documents, no representations or warranties have been made to the Subscriber
by
the Company or any agent, employee or affiliate of the Company and, in entering
into this transaction, the Subscriber is not relying on any information other
than that contained in the Offering Documents and the results of independent
investigation by the Subscriber.
1.17 All
information provided by the Subscriber in the Investor Questionnaire attached
as
Exhibit
B
to this
Subscription Agreement is true and accurate in all respects, and the Subscriber
acknowledges that the Company will be relying on such information to its
possible detriment in deciding whether the Company can sell these securities
to
the Subscriber without giving rise to the loss of the exemption from
registration under applicable securities laws.
II.
|
REPRESENTATIONS
BY
THE COMPANY
|
The
Company represents and warrants to the Subscriber that as of the date of the
closing of this Offering (the “Closing
Date”):
(a) The
Company is a corporation duly incorporated, validly existing and in good
standing under the laws of the State of Delaware and has the corporate power
to
conduct the business which it conducts and proposes to conduct.
(b) The
execution, delivery and performance of this Subscription Agreement by the
Company have been duly authorized by the Company and all other corporate action
required to authorize and consummate the offer and sale of the Units has been
duly taken and approved.
(c) The
Units
and the underlying Common Stock have been duly and validly authorized and
issued.
(d) The
Company is not in violation of or default under, nor will the execution and
delivery of this Subscription Agreement or the issuance of the Common Stock,
or
the consummation of the transactions herein contemplated, result in a violation
of, or constitute a default under, the Company’s Certificate of Incorporation or
By-laws, any material obligations, agreements, covenants or conditions contained
in any bond, debenture, note or other evidence of indebtedness or in any
material contract, indenture, mortgage, loan agreement, lease, joint venture
or
other agreement or instrument to which the Company is a party or by which it
or
any of its properties may be bound or any material order, rule, regulation,
writ, injunction, or decree of any government, governmental instrumentality
or
court, domestic or foreign.
4
(e) The
Company is subject to, and in full compliance with, the reporting requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the
“Exchange
Act”).
The
Company has made available to each Subscriber through the XXXXX system true
and
complete copies of the Company’s Annual and Quarterly Reports on Form 10-KSB and
10-QSB, respectively, and each of the Company’s Current Reports on Form 8-K
(collectively, the “SEC
Filings”),
and
all such SEC Filings are incorporated herein by reference. The SEC Filings,
including the financial statements included therein, when they were filed with
the SEC (or, if any amendment with respect to any such document was filed,
when
such amendment was filed), complied in all material respects with the applicable
requirements of the Exchange Act and the rules and regulations thereunder and
did not, as of such date, contain an untrue statement of a material fact or
omit
to state a material fact required to be stated therein or necessary in order
to
make the statements therein, in the light of the circumstances under which
they
were made, not misleading.
III.
|
TERMS
OF SUBSCRIPTION
|
3.1 The
Subscriber has effected a wire transfer in the full amount of the purchase
price
for the Units to the Company in accordance with the wire instructions attached
as Exhibit
A
to this
Subscription Agreement.
3.2 The
Subscriber hereby authorizes and directs the Company to deliver any certificates
or other written instruments representing the Units to be issued to such
Subscriber pursuant to this Subscription Agreement to the address indicated
on
the signature page hereof.
3.3 If
the
Subscriber is not a United States person, such Subscriber shall immediately
notify the Company and the Subscriber hereby represents that the Subscriber
is
satisfied as to the full observance of the laws of its jurisdiction in
connection with any invitation to subscribe for the Units or any use of this
Subscription Agreement, including (i) the legal requirements within its
jurisdiction for the purchase of the Units, (ii) any foreign exchange
restrictions applicable to such purchase, (iii) any governmental or other
consents that may need to be obtained, and (iv) the income tax and other tax
consequences, if any, that may be relevant to the purchase, holding, redemption,
sale or transfer of the Units. Such Subscriber’s subscription and payment for,
and continued beneficial ownership of, the Units will not violate any applicable
securities or other laws of the Subscriber’s jurisdiction.
IV.
|
MISCELLANEOUS
|
4.1 Any
notice or other communication given hereunder shall be deemed sufficient if
in
writing and sent by reputable overnight courier, facsimile (with receipt of
confirmation) or registered or certified mail, return receipt requested,
addressed to the Company, 0000 Xxxxxxxxx Xxxxxx, Xxxxx 000, Xx Xxxxx,
Xxxxxxxxxx, 00000, Attention: Chief Financial Officer, facsimile: (000)
000-0000, and to the Subscriber at the address or facsimile number indicated
on
the signature page hereof. Notices shall be deemed to have been given on the
date when mailed or sent by facsimile transmission or overnight courier, except
notices of change of address, which shall be deemed to have been given when
received.
4.2 This
Subscription Agreement shall not be changed, modified or amended except by
a
writing signed by both (a) the Company and (b) subscribers in the Offering
holding a majority of the Units issued in the Offering.
4.3 This
Subscription Agreement shall be binding upon and inure to the benefit of the
parties hereto and to their respective heirs, legal representatives, successors
and assigns. This Subscription Agreement sets forth the entire agreement and
understanding between the parties as to the subject matter hereof and merges
and
supersedes all prior discussions, agreements and understandings of any and
every
nature among them.
5
4.4 Notwithstanding
the place where this Subscription Agreement may be executed by any of the
parties hereto, the parties expressly agree that all the terms and provisions
hereof shall be construed in accordance with and governed by the laws of the
State of Delaware. The parties hereby agree that any dispute which may arise
between them arising out of or in connection with this Subscription Agreement
shall be adjudicated only before a Federal court located in Kent County, State
of Delaware and they hereby submit to the exclusive jurisdiction of the federal
courts located in Kent County, State of Delaware with respect to any action
or
legal proceeding commenced by any party, and irrevocably waive any objection
they now or hereafter may have respecting the venue of any such action or
proceeding brought in such a court or respecting the fact that such court is
an
inconvenient forum, relating to or arising out of this Subscription Agreement
or
any acts or omissions relating to the sale of the securities hereunder, and
consent to the service of process in any such action or legal proceeding by
means of registered or certified mail, return receipt requested, in care of
the
address set forth below or such other address as the undersigned shall furnish
in writing to the other. The parties further agree that in the event of any
dispute, action, suit or other proceeding arising out of or in connection with
this Subscription Agreement or other matters related to this subscription
brought by a Subscriber (or transferee), the Company (and each other defendant)
shall recover all of such party’s attorneys’ fees and costs incurred in each and
every action, suit or other proceeding, including any and all appeals or
petitions therefrom. As used herein, attorney’s fees shall be deemed to mean the
full and actual costs of any investigation and of legal services actually
performed in connection with the matters involved, calculated on the basis
of
the usual fee charged by the attorneys performing such services.
4.5 This
Subscription Agreement may be executed in counterparts. Upon the execution
and
delivery of this Subscription Agreement by the Subscriber, this Subscription
Agreement shall become a binding obligation of the Subscriber with respect
to
the purchase of Units as herein provided; subject, however, to the right hereby
reserved by the Company to (i) enter into the same agreements with other
subscribers, (ii) add and/or delete other persons as subscribers and (iii)
reduce the amount of or reject any subscription.
4.6 The
holding of any provision of this Subscription Agreement to be invalid or
unenforceable by a court of competent jurisdiction shall not affect any other
provision of this Subscription Agreement, which shall remain in full force
and
effect.
4.7 It
is
agreed that a waiver by either party of a breach of any provision of this
Subscription Agreement shall not operate or be construed as a waiver of any
subsequent breach by that same party.
4.8 The
parties agree to execute and deliver all such further documents, agreements
and
instruments and take such other and further actions as may be necessary or
appropriate to carry out the purposes and intent of this Subscription
Agreement.
[Signature
Pages Follow]
6
IN
WITNESS WHEREOF,
the
parties have executed this Subscription Agreement as of the day and year first
written above.
__________________________
|
X
$110,000 for each Unit
|
=
$_____________________.
|
Number
of Units subscribed for
|
Aggregate
Purchase Price
|
Manner
in which Title is to be held (Please Check One):
1.
|
___
|
Individual
|
7.
|
___
|
Trust/Estate/Pension
or Profit Sharing Plan
Date
Opened:______________
|
2.
|
___
|
Joint
Tenants with Right of Survivorship
|
8.
|
___
|
As
a Custodian for
________________________________
Under
the Uniform Gift to Minors Act of the State of
________________________________
|
3.
|
___
|
Community
Property
|
9.
|
___
|
Married
with Separate Property
|
4.
|
___
|
Tenants
in Common
|
10.
|
___
|
Xxxxx
|
5.
|
___
|
Corporation/Partnership/
Limited Liability Company
|
11.
|
___
|
Tenants
by the Entirety
|
6.
|
___
|
XXX
|
12.
|
___
|
Foundation
described in Section 501(c)(3) of the Internal Revenue Code of 1986,
as
amended.
|
IF
MORE THAN ONE SUBSCRIBER,
EACH SUBSCRIBER MUST SIGN:
· INDIVIDUAL
SUBSCRIBERS MUST COMPLETE PAGE 8
· SUBSCRIBERS
WHICH ARE ENTITIES MUST COMPLETE PAGE 9
7
EXECUTION
BY NATURAL PERSONS
_____________________________________________________________________________
Exact
Name in Which Title is to be Held
|
||
Name
(Please Print)
|
Name
of Additional Subscriber
|
|
Residence:
Number and Street
|
Address
of Additional Subscriber
|
|
City,
State and Zip Code
|
City,
State and Zip Code
|
|
Social
Security Number
|
Social
Security Number
|
|
Telephone
Number
|
Telephone
Number
|
|
Fax
Number (if available)
|
Fax
Number (if available)
|
|
E-Mail
(if available)
|
E-Mail
(if available)
|
|
(Signature)
|
(Signature
of Additional Subscriber)
|
|
ACCEPTED
this ___ day of _________ 2008, on behalf of Transdel Pharmaceuticals,
Inc.
|
||
By:_______________________
Name:
Xxxxxx Xxxxx, Ph.D.
Title:
Chief Executive Officer
|
8
EXECUTION
BY SUBSCRIBER WHICH IS AN ENTITY
(Corporation,
Partnership, Trust, Etc.)
____________________________________________________________________________
Name
of Entity (Please Print)
|
|
Date
of Incorporation or Organization:
|
|
State
of Principal Office:
|
|
Federal
Taxpayer Identification Number:
____________________________________________
Office
Address
____________________________________________
City,
State and Zip Code
____________________________________________
Telephone
Number
____________________________________________
Fax
Number (if available)
____________________________________________
E-Mail
(if available)
|
|
[seal]
Attest:
(If
Entity is a Corporation)
|
By: _______________________
Name:
Title:
|
*If
Subscriber is a Registered Representative with an NASD member firm,
have
the following acknowledgement signed by the appropriate
party:
|
|
The
undersigned NASD member firm acknowledges receipt of the
notice
required
by Rule 3050 of the NASD
Conduct
Rules
|
|
Name
of NASD Firm
|
ACCEPTED
this ____ day of __________ 2008, on behalf of Transdel Pharmaceuticals,
Inc.
|
By:
_______________________
Name:
Title:
|
By:
_______________________
Name:
Xxxxxx Xxxxx, Ph.D.
Title:
Chief Executive Officer
|
9